Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04985383
What this trial is testing

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

Who this might be right for
End-Stage Renal Disease
Alkahest, Inc. 10
Post-approval studies (Phase 4)Study completedNCT01903070
What this trial is testing

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

Who this might be right for
Diabetes Mellitus
Profil Institut für Stoffwechselforschung GmbH 99
Post-approval studies (Phase 4)Study completedNCT00369772
What this trial is testing

STAAR-1 Clinical Study

Who this might be right for
Chronic Kidney DiseaseChronic Renal InsufficiencyKidney Disease+2 more
Amgen 2,000
Early research (Phase 1)Ended earlyNCT00721422
What this trial is testing

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

Who this might be right for
Renal InsufficiencyPharmacokinetics
Pfizer 16
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Large-scale testing (Phase 3)WithdrawnNCT05082584
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00761657
What this trial is testing

Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis

Who this might be right for
Chronic Kidney DiseaseAnemia
Kyntra Bio 117
Early research (Phase 1)Study completedNCT05004311
What this trial is testing

The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics

Who this might be right for
HealthyRenal Impairment
Viatris Innovation GmbH 16
Not applicableStudy completedNCT04511338
What this trial is testing

Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™

Who this might be right for
Chronic Kidney DiseasesPatient Requiring Heparin Free Dialysis Treatments
Fresenius Medical Care North America 16
Early research (Phase 1)Study completedNCT02653014
What this trial is testing

Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment

Who this might be right for
HealthyRenal Insufficiency
KBP Biosciences 26
Large-scale testing (Phase 3)Study completedNCT00156949
What this trial is testing

EPO Deep Tank in Dialysis Subjects

Who this might be right for
Chronic Kidney Disease
Amgen 580
Large-scale testing (Phase 3)Study completedNCT03350321
What this trial is testing

Molidustat for Correction of Renal Anemia in Non-dialysis Subjects

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 162
Early research (Phase 1)Study completedNCT02508506
What this trial is testing

Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Alkermes, Inc. 22
Early research (Phase 1)Study completedNCT03310463
What this trial is testing

Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects

Who this might be right for
Acinetobacter Baumannii Infection
Entasis Therapeutics 34
Early research (Phase 1)Study completedNCT01937975
What this trial is testing

The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050)

Who this might be right for
Chronic Hepatitis CRenal Impairment
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Study completedNCT04859439
What this trial is testing

Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40
Early research (Phase 1)Study completedNCT02807077
What this trial is testing

PK of Pacritinib in Patients With Mild, Moderate, Severe Renal Impairment and ESRD Compared to Healthy Subjects

Who this might be right for
Myelofibrosis
CTI BioPharma 40
Early research (Phase 1)Study completedNCT02182024
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 35
Early research (Phase 1)WithdrawnNCT01468259
What this trial is testing

A Multi-Center, Open-Label Study

Who this might be right for
Renal DiseaseEnd Stage Renal Disease
Chelsea Therapeutics
Early research (Phase 1)Study completedNCT00805090
What this trial is testing

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Who this might be right for
Renal Insufficiency, ChronicHepatic InsufficiencyHealthy
Javelin Pharmaceuticals 37
Next Page